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The free radical nitric oxide (NO) is an important signaling molecule in the gastrointestinal tract. Besides eukaryotic cells, gut
microorganisms are also capable of producing NO. However, the exact mechanism of NO production by the gut microorganisms
is unknown. Microbial NO production was examined under in vitro conditions simulating the gastrointestinal ecosystem using
L-arginine or nitrate as substrates. L-arginine did not inﬂuence the microbial NO production. However, NO concentrations in
the order of 90ng NO-N per L feed medium were produced by the fecal microbiota from nitrate. 15N tracer experiments showed
that nitrate was mainly reduced to ammonium by the dissimilatory nitrate reduction to ammonium (DNRA) pathway. To our
knowledge, this is the ﬁrst study showing that gastrointestinal microbiota can generate substantial amounts of NO by DNRA and
not by the generally accepted denitriﬁcation or L-arginine pathway. Further work is needed to elucidate the exact role between NO
produced by the gastrointestinal microbiota and host cells.
Copyright © 2009 Joan Vermeiren et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Nitricoxide(NO),afreeradicalwithmoderatereactivity,has
emerged as an important signaling molecule in a multitude
of physiological systems in the human body [1]. In the
gastrointestinal tract, NO is involved in the regulation of
regional blood ﬂow, smooth muscle relaxation, secretory
and immunological regulation [2]. During inﬂammation the
production of NO is induced. Rectal NO concentrations in
healthy volunteers (range 3–25ppbv) are signiﬁcantly lower
than the concentrations in patients with active inﬂammatory
bowel disease (IBD) (range 71–8978ppbv) [3]. NO can
be synthesized in eukaryotic cells through oxidation of L-
arginine by NO synthase (NOS) [4, 5]. Depending on
the isoform of NOS catalyzing the reaction, nanomo-
lar (endothelial NOS and neuronal NOS) or micromolar
(inducible NOS) NO concentrations are produced serving as
a messenger or as an antibacterial agent. Besides eukaryotic
N Op r o d u c t i o n ,i ti sw e l lk n o w nt h a tN Oc a nb ep r o d u c e d
also by microorganisms.
A ﬁrst way of microbial NO synthesis can be achieved
from L-arginine by bacterial NOS (bNOS) with features
resembling the eukaryotic NOS (eukNOS). bNOS activity
has been described in a group of Gram-positive bacteria
[6–14] and genome sequencing has revealed genes coding
for similar proteins that are however shorter than the
eukNOS [15]. bNOS from Bacillus subtilis, Bacillusanthracis,
Deinococcus radiodurans, and Streptomyces spp. display NO-
forming activity in vivo dependent on arginine [14–17].
Besides L-arginine, nitrate and nitrite can also serve as an
N - s o u r c ef o rN O .P e rd a y ,b e t w e e n0a n d1 0 m gN O 3
−-N
can reach the large intestine in healthy persons [18]. Feces
were shown to contain around 0.15mg NO3
−-N/L [3]. In
vitro studies showed a correlation between the concentration
of the added nitrate or nitrite and the concentration of
NO produced by the fecal microbiota [19]. The metabolic
process best known for the microbial production of NO, and
extensively described in soils, sediments and water treatment
plants, is denitriﬁcation [20]. This dissimilatory process
uses oxidized nitrogen species as ﬁnal electron acceptors
when oxygen levels are limiting. During the denitriﬁcation
process nitrate or nitrite is reduced to N2 gas with NO and
N2O as intermediates [21]. At steady-state conditions, the
NO concentrations range between 14 and 900ng NO-N/L2 Journal of Biomedicine and Biotechnology
aqueous phase depending on species and conditions [22].
Another NO producing mechanism is by the reduction of
nitrite. For lactobacilli and biﬁdobacteria it is not clear
whether NO production from nitrite occurred biologically
or chemically. Hence, acidic nonenzymatic reduction of
nitrite was suggested as the predominant pathway for
NO production in vitro by lactic acid producing bacteria
(lactobacilli and biﬁdobacteria) as the produced organic
acids decrease the pH of the agar plates to 4 [19]. Whereas
NO production by lactic acid bacteria was considered to be
chemical, NO production from nitrite by Escherichia coli and
Salmonella typhimurium was shown to be biological. The
enzymes responsible for the NO formation from nitrite in
E. coli and S. typhimurium are periplasmic and cytoplasmic
nitrite reductase and nitrate reductase, respectively [23, 24].
To date, the relevance and mechanism of bacterial NO
production under gastrointestinal conditions remain elusive.
With NO being produced by inducible NOS in epithelial
cells as a response to cytokines and bacterial products [25],
it is of interest to know whether bacterial NO production
can occur under gastrointestinal conditions. The objective of
our study was to unravel the mechanisms by which human
fecal microbiota are able to produce NO in vitro. Three
possible pathways were considered (i) L-arginine as substrate
for NO synthase, (ii) denitriﬁcation to nitrogen gas and
(iii) dissimilatory nitrate reduction to ammonium (DNRA).
The latter was considered as fermentative nitrate reduction
is expected under gastrointestinal conditions however no
relation with NO production has been considered [26, 27].
2.MaterialsandMethods
2.1. Growth Media. NO production was examined in a min-
eral and a complex medium. The mineral medium G4M3 is
a medium optimized for denitriﬁcation [28]. Feed medium
is a complex medium simulating the nutritional conditions
in the colon. It is composed of arabinogalacton (1g/L),
pectin (2g/L), xylan (1g/L), starch (3g/L), glucose (0.4g/L),
yeast extract (3g/L), peptone (1g/L), mucin (4g/L), and
L-cysteine (0.5g/L) [29]. L-cysteine was added to scavenge
dissolved oxygen and to lower the initial redox potential.
Analyses of the feed medium with ion chromatography
indicated that very low concentrations of nitrate, that is,
110 ±50μgN O 3
−-N/L, were present.
2.2. Fecal Suspensions. Fecal samples were obtained from 6
healthy women with a mean age of 55.5 ranging between
53 and 59. Fecal suspensions were prepared and stored at
−80
◦C until use [30]. The main group of organisms in fecal
samples belongs to the anaerobic Gram-positive bacteria.
Anaerobic populations belonging to the genera Bacteroidetes
and Firmicutes dominate [31, 32].
Incubations were performed with fecal suspension of
diﬀerent healthy persons which all showed similar results. In
the ﬁgures, the results of incubations of one representative
person are shown.
2.3. Batch Experiments. Anaerobic incubations were per-
formed in penicillin ﬂasks with a total volume of 120mL.
The bottles were ﬁlled with 50mL of one of the growth
media and the pH was set at 7.0 using a 1M NaOH solution.
The headspace (70mL) was ﬂushed for 45 minutes with
N2-gas to create anaerobic conditions. Diﬀerent parameters
(growth media, concentrations of nitrate and L-arginine,
pH, dilution of the fecal suspension and supernatant) were
varied to examine their eﬀect on the production of NO, as
described in Figure 1. For mineral media the concentration
of nitrate added was the only parameter tested. Nitrate as a
possible N-source for NO was added in concentrations of 5
and 50mg NO3
−-N/L using a 14g NaNO3
−-N/L solution.
To study L-arginine as N-source, a stock solution of 3.5g
(L-arginine-HCl)-N/L was added to ﬁnal concentrations
of 5 and 50mg L-arginine-N/L. When incubations were
performed in buﬀered feed medium, a 1M phosphate buﬀer
(88g K2HPO4/L and 68g KH2PO4/L) was added to a ﬁnal
concentration of 150mM. The pH was measured before and
after incubation. Dilutions of the fecal suspension (1/2, 1/10,
1/20, 1/200, and 1/2000) were made in saline (8.5g NaCl/L).
Both for the undiluted and diluted fecal suspensions, 1mL
was inoculated in the growth medium. To study the eﬀect of
the supernatant of the fecal suspension on NO production,
the fecal suspension was centrifuged at 10000g for 15
minutes. The supernatant was collected and 1mL was added
to the growth medium. The penicillin ﬂasks were incubated
at 37
◦C for 24 hours while shaking at 130rpm.
To assess the production of NO during DNRA,
EscherichiacoliK12(LMG18221)(BCCMculturecollection,
Ghent University, Gent, Belgium) was grown anaerobically
for 24 hours at 37
◦Ci nb u ﬀered feed medium without
additional nitrate.
2.4. 15NB a t c hE x p e r i m e n t s .To determine the reduction of
nitrate to N2 or ammonium by, respectively, denitriﬁcation
or DNRA, an experiment was set up as described in the
section above but using a 14g K15NO3
−-N/L (10 atom %)
solution to ﬁnal concentrations of 5 and 50mg 15NO3
−-N/L
(10 atom %). Atom % =15N/(14N+ 15N). The headspace was
ﬂushed with Argon gas to avoid interference during 15N2
analyses. Fecal suspensions were added undiluted.
2.5. Simulator of the Human Intestinal Microbial Ecosystem
(SHIME). The reactor setup was adapted from the SHIME,
representing the diﬀerent parts of the adult human gut and
consisting of a succession of 5 compartments [29]. The ﬁrst
2 compartments are a ﬁll-and-draw setup and represent
the stomach and small intestine. Peristaltic pumps add a
deﬁned amount of feed medium (140mL, 3 times/day) and
pancreatic and bile liquid (60mL, 3 times/day), respectively,
tothestomachandduodenumcompartmentsandemptythe
respective compartments after speciﬁed intervals. The last 3
compartments are continuously stirred reactors with con-
stantvolumeandpHcontrol,speciﬁcforeachcompartment.
Uponinoculationwithfecalmicrobiota,thesereactorssimu-
late the ascending, transverse, and descending colon. Inocu-
lum preparation, retention time, pH, temperature settings,
andreactorfeedcompositionweredescribedpreviously[33].
Closingoﬀthegasphaseofthediﬀerentcoloncompartments
(ascending, transverse, and descending) upon N2 ﬂushingJournal of Biomedicine and Biotechnology 3
Feed medium
No buﬀer Buﬀer
0.11mg NO3
−-N/L +5mg NO3
−-N/L +50mg NO3
−-N/L 0.11mg NO3
−-N/L +5mg NO3
−-N/L +50mg NO3
−-N/L
Diluted fecal slurry
Supernatant
Figure 1: Overview of the experimental setup for the diﬀerent parameters that were studied using feed medium simulating the conditions
in the human colon.
allowed to study the NO production in the respective colon
regions separately. Gas samples were collected and analyzed
for NO. Samples of the diﬀerent SHIME vessels of the 3
colon parts were collected. All the incubations were done
anaerobically in penicillin ﬂasks of 120mL, as described
previously. The suspensions were incubated as such or with
20mL fresh feed medium. To test the eﬀect of the biomass,
the biomass of the suspensions was washed 3 times with
saline and resuspended in feed medium. The supernatant
was prepared by centrifuging the suspension at 10000g
for 15 minutes. The supernatant was ﬁltersterilized using
0.22μm membrane ﬁlters (Millipore, NYSE:MIL, USA) or
autoclaved.
2.6. Analytical Methods. Both NO3
− and NO2
− concentra-
tions were measured before and after incubation of fecal
suspension in growth media supplemented with NO3
−.
A Metrohm 761 Compact Ion Chromatograph (Metrohm
AG, Herisau, Switzerland) equipped with a conductivity
d e t e c t o ra n daM e t r o s e pAs u p p5c o l u m nw a su s e d .
The operational parameters were as follows: eluent 1.06g
Na2CO3/L;ﬂow0.7mL/min;sampleloop20μL.Thesamples
were centrifuged at 4000g for 3 minutes, ﬁltered using
0.45μm membrane ﬁlters, and diluted in milli-Q water
before analysis (Millipore, NYSE:MIL, USA).
During 15N experiments, NH4
+ concentrations were
determined colorimetrically by the salicylate-nitroprusside
method[34].TheamountofNO3
− andNO2
− wasmeasured
by ﬁrst reducing NO3
− to NO2
− by a copper-cadmium
redactor coil at pH of 8.0. NO2
− concentrations were deter-
mined colorimetrically by an imidazole buﬀered reaction
with N-1-naphtylethylenediamine. The NO3
− concentration
was quantiﬁed by subtraction of the concentrations of
NO2
− from the concentration of (NO3
− +N O 2
−)[ 35]. The
samples were centrifuged at 4000g for 3 minutes, ﬁltered
using 0.45μm membrane ﬁlters, and diluted in milli-Q
water before analysis (Millipore, NYSE:MIL, USA). 15NH4
+
analyses were performed after conversion to N2O using a
trace gas preconcentration unit (ANCA-TGII, SerCON, UK)
c o u p l e dt oa ni s o t o p er a t i om a s ss p e c t r o m e t e r( I R M S )( 2 0 -
20, SerCon, UK) [35, 36]. To determine the 15N/14Nr a t i o
of the biomass, the samples were centrifuged at 1750g for
15 minutes and the pellet was dried at 60
◦C overnight. The
15N/14N ratio was determined by an Elemental Analyzer
(EA) (ANCA-SL, SerCON, UK) coupled to the IRMS (20-20,
SerCon, UK). Analyses were triplicated.
NO measurements were done based on the principle
of chemiluminescence using Eco Physics CLD 77 AM (Eco
Physics AG, Duernten, Switzerland) with a detection limit
of 1ppbv. Gas samples of 25mL were collected in syringes
from the headspace of the penicillin ﬂasks after 24 hours
of anaerobic incubation. The concentrations were calculated
by comparison with a standard curve prepared with NO
standard gas (98 ±0.5 ppmv) diluted in air.
For N2O measurements, 6mL of gas from the headspace
was collected in a vacutainer with a total volume of 12mL
(Labco limited, Buckinghamshire, UK). OnemL of this
dilution was used for analysis with a Shimadzu GC-14B gas
chromatograph (Shimadzu, Kyoto, Japan) with an electron
capture detector (ECD) and two packed columns (Porapack
Q, 80/100 mesh, 1 and 2m). The operating conditions were
as follows: carrier gas N2 (55mL/min), injector temperature
105
◦C, column and oven temperature 35
◦C, and detector
temperature250
◦C.Thechromatographwascalibratedusing
N2O standard gas (250 ± 13 ppmv or 25.3 ± 1.5 ppmv
in He).
For N2 analyses, 12mL of gas from the headspace was
collected in a vacutainer (Labco limited, Buckinghamshire,
UK). The gas was analyzed with a Finnigan Trace Ultra
GC (Interscience, Breda, The Netherlands) with a thermal
conductivity detector (TCD), a precolumn (Hayesep Q,
80/100 mesh, 0.25m) and 2 packed columns (Hayesep Q,4 Journal of Biomedicine and Biotechnology
80/100 mesh, 2m and Molsieve 5˚ A, 80/100 mesh, 2m). The
injector temperature was 65
◦C and oven temperature 90
◦C.
2.7. Calculations. All NO and N2Om e a s u r e m e n t sw e r es u b -
sequently converted to concentrations present in the growth
medium. The NO and N2O concentrations measured in the
gas phase (ppbv) were converted to molar concentrations
using the ideal gas law pV = nRT withT = 294.65K. Taking
into account [NO]g/[NO]aq ∼ = 20 and [N2O]g/[N2O]aq ∼ =
1.64 at equilibrium, the NO and N2O concentrations in the
gas phase were converted to the concentration in the liquid
phase and expressed as g NO-N or N2O-N per L.
2.8. Statistical Analysis. SPSS version 16.0 (SPSS Inc.,
Chicago, USA) was used to carry out all statistical analyses.
Normality of the data and homogeneity of variances was
assessed using the Kolmogorov-Smirnov and the Levene
test, respectively. Comparison of normally distributed data
was performed with ANOVA or Tamhane; when ANOVA
indicatedsigniﬁcantdiﬀerences,meanswerecomparedusing
the Bonferroni comparison test. Comparison of means
of not normally distributed data was evaluated with the
nonparametric Kruskal-Wallis test; when Kruskal-Wallis
indicatedsigniﬁcantdiﬀerences,meanswerecomparedusing
the Mann-Whitney comparison test. A P-value of less than
0.05 was considered signiﬁcant.
3. Results
3.1. L-Arginine as N-Source forNO and N2O Production. The
biological production of NO with L-arginine as substrate
was studied by supplementing mineral medium and feed
medium with 0, 5, or 50mg L-arginine-N/L. Medium
supplementedwith50mgL-arginine-N/Lbutnotinoculated
with fecal suspension, served as a negative control. The
pH was set at 7 and NO and N2O concentrations were
analyzed after 24 hours. When L-arginine was supplemented
to the mineral medium, only traces of NO (0.28ng NO-
N/L medium) could be detected for all the L-arginine con-
centrations. In feed medium, the mean NO concentration
after 24 hours was for all the samples around 75ng NO-N/L
medium. No proportional eﬀect of L-arginine on the NO
production could be observed. No N2O was detected in any
of the samples.
3.2. Nitrate as N-Source for NO and N2Oi nM i n e r a lM e d i a
Optimized for Denitriﬁcation. F e c a lm i c r o b i o t aw e r et e s t e d
for their ability to produce NO and N2O by denitriﬁcation.
Fecal suspensions were inoculated anaerobically for 24
hours in mineral media (with succinate as electron donor)
containing 0, 5, or 50mg NO3
−-N/L. Nitrate was completely
consumed for all biotic conditions. None of the samples
contained nitrite in the beginning or at the end of the
incubation and after 24 hours the mean pH was 6.53 ± 0.35.
After 24 hours of incubation, the NO concentrations in
the mineral media remained below 1ng NO-N/L medium
in all experiments (Figure 2(a)). A proportional eﬀect was
observed for N2O production and the amount of supplied
nitrate (Figure 2(b)). The fecal microbiota without added
nitrate did not produce N2O. However, addition of 5 and
50mg NO3
−-N/L resulted in signiﬁcant N2O production.
3.3. Nitrate as N-Source for NO and N2Oi nF e e dM e d i u m
3.3.1. Nitrate as N-Source for NO and N2Oi nN o n b u ﬀered
Feed Medium. To examine whether microbiological produc-
tion of NO and N2O was possible under gastrointestinal
conditions, fecal microbiota were grown in the presence of
a complex medium simulating the conditions in the colon
(Figure 1). The feed medium was analyzed for nitrate and
ab a c k g r o u n do f0 . 1 1 m gN O 3
−-N/L was measured. The
preparation of feed medium without trace levels of nitrate
was not possible. After 24 hours of incubation, the pH
dropped to 4.13 ± 0.05, 4.24 ± 0.03 and 4.47 ± 0.03 for 0.11,
5a n d5 0m gN O 3
−-N/L, respectively. The concentrations of
nitrate measured after 24 hours were below 0.5mg NO3
−-
N/L for all biotic conditions. Nitrite at time 0 was below
0.1mg NO2
−-N/L but after 24 hours concentrations of 0.1±
0.1and2.0±0.2mgNO 2
−-N/Lweredetectedfor5and50mg
NO3
−-N/L, respectively. Figures 2(c) and 2(d) show the
concentrationsofNOandN2Omeasuredafter24hours.The
NO concentration measured in the medium without nitrate
addition was 37.0 ± 0.3ng NO-N/L. The addition of 5mg
NO3
−-N/L increased the NO concentration slightly to 44.1±
2.5ng NO-N/L medium. However the addition of 50mg/L
NO3
−-NincreasedtheNOconcentrationdrasticallyto298±
33μg NO-N/L medium. As for the mineral media, a positive
eﬀect for the N2O production with the supplemented nitrate
was observed.
3.3.2. Nitrate as N-source for NO and N2Oi nB u ﬀered Feed
Medium. The same experimental setup as described above
was used but under buﬀered conditions (measured pH
was always between 6 and 6.8), thus avoiding fermentative
acidiﬁcation during biotic incubations. Nitrate concentra-
tions decreased after 24 hours to 1.0 ± 1.5a n d3 .1 ± 1.9mg
NO3
−-N/L for 5mg and 50mg NO3
−-N/L respectively. No
nitrite was detected. As shown in Figures 2(e) and 2(f),
the NO concentrations increased slightly when nitrate was
added. The concentration of N2Oi nb u ﬀered feed medium
supplemented with 5mg NO3
−-N/L was comparable to the
concentration measured in the nonbuﬀered test reported
above. For the highest concentration of nitrate a lower N2O
concentrationwasdetectedcomparedtothenonbuﬀeredtest
(Figure 2).
3.4. 15N Experiment. A 15N tracer study was used to link
nitrate consumption to denitriﬁcation or DNRA by the fecal
microbiota under gastrointestinal conditions. The setup was
the same as for the buﬀered feed medium but K15NO3 (10
atom %) was used as N-source in 2 diﬀerent concentrations,
that is, 5 and 50mg 15NO3
−-N/L (Figure 1). Table 1 gives an
overview of the nitrogen concentrations measured and the
recovery of 15N after 24 hours of anaerobic incubation. After
24 hours all nitrate was reduced and the control maintained
41.3 ± 4.5mg NO 3
−-N/L. The nitrite concentrations were
stable over 24 hours of anaerobic incubation. The amount
of NO and N2O produced per volume of feed medium wasJournal of Biomedicine and Biotechnology 5
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Figure 2: NO-N and N2O-N concentrations produced after 24 hours of anaerobic incubation of the human fecal microbiota in mineral
medium (a), (b), nonbuﬀered feed medium (c), (d), or buﬀered feed medium (e), (f) with or without the addition of nitrate (n = 3).
Signiﬁcant diﬀerences are indicated with a, b, or c (P<. 05). Results are means ± standard deviation of 3 incubations of fecal suspension
from 1 representative person.6 Journal of Biomedicine and Biotechnology
Table 1: Nitrogen concentrations measured after 24 hours of anaerobic incubation of fecal microbiota in feed medium supplemented with
K15NO3(10 atom %). The N2 concentration measured in the control is subtracted from the concentrations measured in the samples. 15NH4
+
and organic 15N are recovered from K15NO3(10 atom %). Results are means ± standard deviation of 3 incubations of fecal suspension from
1 representative person.
5mg15NO3
−-N/L 50mg 15NO3
−-N/L 50mg 15NO3
−-N/L abiotic control
Nitrate-N (mg/L) 0 0 41.3 ±4.5
Nitrite-N (mg/L) 0.1 ±0.02 0.08 ±0.01 0.4 ±0.03
NO-N (ng/L) 111 ±5a 215 ±1b 2.3 ±0.4c
N2O-N (ng/L) 4020 ±246a 58553 ±4837b 0c
N2 00 —
15NH4
+ (atom %) > 10 >10 0
Organic 15N( a t o m% ) 0 .05 ±0.03 0.14 ±0.03 0
abc signiﬁcant diﬀerences between a, b, and c (P<. 05).
in the same range as what was found in the buﬀered feed
medium experiment (Table 1). High ammonium concentra-
tions, 56.5 ± 6.1mg NH 4
+-N/L, were present in the feed
medium at time 0. After 24 hours, concentrations reached
182±4, 210±1, 275±6, and 50.1±2.6mgNH 4
+-N/L for no
extra, 5mg NO3
−- N / L ,5 0m gN O 3
−-N/L, and the chemical
control, respectively.
3.5. NO Production in Buﬀered Feed Medium During DNRA.
To verify if NO can be produced as a side product or as
an intermediate during DNRA, E. coli LMG 18221, a strain
capable of DNRA but not denitriﬁcation was grown anaero-
bically at 37
◦Ci nb u ﬀered feed medium. After 24 hours, NO
concentrations of 170ng NO-N/L medium were measured.
This NO concentration was twice as high compared to NO
concentrations produced by the fecal cultures.
3.6. Inhibitory Eﬀect of Fecal Supernatant on NO Production.
Figure 3(a) shows that diluting the fecal suspension 200
times before inoculation in buﬀered feed medium results
in a 75% increase in the NO concentration. There was
ad i ﬀerence in the NO concentration related to the fecal
suspension and optimal dilution. The optimal dilution
ranged between 1/20 and 1/200 and the increase of NO
between 50 and 75%, respectively. Higher dilutions than
1/200 yielded lower NO concentrations. The addition of
supernatant from a fecal suspension resulted in a decrease
of the NO concentration (Figure 3(b)).
3.7. Production of NO in the Colon Vessels of the SHIME. A
continuous model that simulates the gastrointestinal tract
(SHIME) was used to measure NO production by human
gastrointestinal microbiota. Feed medium containing trace
levels of nitrate (110 ± 50μgN O 3
−-N/L) is used to simulate
the nutritional conditions. The NO concentrations in the
headspace of the 3 colon vessels were analyzed after an
incubation period of 24 hours. In the colon ascendens,
101ng NO-N/L SHIME suspension was measured but lower
concentrations were found in the colon transversum and
descendens (5.4 and 8.5ng NO-N/L SHIME suspension,
respectively). A batch setup was performed to test whether
this diﬀerence was due to (i) the microbial community or
(ii) the availability of nutrients in the diﬀerent colon com-
partments.Thebiomassofthediﬀerentcoloncompartments
was washed and grown anaerobically in fresh feed medium
for 24 hours. As references, the microbial suspensions of
the diﬀerent colon vessels were incubated in parallel in
penicillin bottles with or without the addition of fresh feed.
To exclude a chemical process, cell-free supernatant of the
SHIME suspension was ﬁltersterilized or autoclaved and
subsequently incubated. Figure 4 shows that the addition of
feed increases the NO concentrations at least 3 times but the
diﬀerence between the ﬁrst colon vessel and the other 2 was
maintained. Incubation of the washed biomass showed that
even higher concentrations of NO were produced (ranging
between 220 and 250ng NO-N/L) and that the supernatant
that was removed might have an inhibitory eﬀect on the NO
production as observed above. No chemical production of
NO was seen when the cell-free supernatant of the SHIME
suspension was incubated.
4. Discussion
Our results demonstrate that the fecal microbiota of healthy
personsareabletoproduceNOinconcentrationsupto90ng
NO-N/L medium when grown in conditions simulating the
colon (Figure 2(e)). Adding L-arginine to the feed medium
inoculated with fecal microbiota of a healthy person had
no eﬀect on the NO production. High amounts of nitrate
in combination with low pH resulted in substantial NO
and N2O production (Figures 2(c) and 2(d)). However, NO
and N2O were also formed under pH buﬀered conditions
(Figures2(e)and2(f)).Thesedatacorroboratethemetabolic
capacity of the fecal microbiota to reduce nitrate and
produce NO. By using 15N tracer experiments, it was shown
that nitrate was mainly reduced to ammonium by DNRA
suggesting that NO was produced as a side product or
intermediate of this pathway. NO was detected not only in
the batch tests but also in the in vitro SHIME model.
Indirect evidence from in vitro studies demonstrates
that extracellular L-arginine increases the NO production
by eukNOS (at concentrations at which the enzyme should
be saturated), known as the “L-arginine paradox” [37, 38]
and some prokaryotic NOS proteins have been shown toJournal of Biomedicine and Biotechnology 7
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Figure 3: NO-N concentrations in function of the diﬀerent
dilutions of fecal suspension (a) and the inhibitory eﬀect of the
supernatant of the fecal slurry (b). The inoculated medium was
incubated anaerobically for 24 hours and the NO-N concentration
measured in the headspace (n = 3). Signiﬁcant diﬀerences are
indicated with a, b, or c (P<. 05). Results are means ± standard
deviation of 3 incubations of fecal suspension from 1 representative
person.
produce NO in vivo [14–17]. However, our results show
that L-arginine does not promote NO production. The
reaction from L-arginine to NO is oxygen dependent what
might explain why L-arginine has no increasing eﬀect during
anaerobic growth of the fecal microbiota. Therefore, we
consider the arginine pathway for bacterial NO production
under gastrointestinal conditions as not important.
In the lower parts of the gastrointestinal tract, nitrate
originates from dietary products rich in nitrate, like spinach,
beetroot, or fennel or simply from minor levels as present
in drinking water [39]. Nitrate is reduced by the bacteria
in the oral cavity or is absorbed in the small intestine. In
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Figure 4: NO-N concentrations produced by the microbiota of
the 3 colon vessels (black = colon ascendens (CA), light grey =
colon transversum (CT), dark grey = colon descendens CD)) of the
in vitro SHIME model measured in the headspace. The microbial
suspension of the 3 vessels was incubated anaerobically for 24 hours
with or without fresh feed medium or washed and resuspended
in fresh feed medium. The supernatant of the SHIME suspension
was incubated as well in the feed medium after ﬁltersterilisation or
autoclavation.
healthy persons, levels in the order ofmg NO3
−-N/L can be
estimated in the large intestine [18] and feces were shown to
contain around 0.15mg NO3
−-N/L [3]. Based on these data,
2d i ﬀerent concentrations of nitrate (5 and 50mg NO3
−-
N/L) were chosen for the in vitro experiments. Very low
concentrations of nitrate were measured in the feed medium
receivingnoadditionalnitrate(110±50μgN O 3
−-N/L),rep-
resentative for the concentrations found in feces. When fecal
suspensions were incubated in nonbuﬀered feed medium
containing50mgNO3
−-N/LveryhighconcentrationsofNO
(29.8μg NO-N/L) were measured. During the incubations,
the pH dropped to a mean value of 4.24 due to the accu-
mulation of organic acids produced by the microorganisms.
At these low pH values, a chemical reduction of nitrite to
NO (pH below 5.5) cannot be excluded [19]. In vivo, the pH
increases over the diﬀerent colon parts. Considering a pH of
6.37 ± 0.58 in the colon ascendens, 6.61 ± 0.83 in the colon
transversum and 7.04 ± 0.67 in the colon descendens [40],
a chemical reduction of nitrite to NO in vivo is not likely.
Because it was unclear whether NO was produced chemically
orbiologically ,abuﬀerwasaddedtostabilizethepHbetween
5.7 and 8. The very high NO concentrations produced
at low pH in feed medium containing the highest nitrate
concentration were not found at neutral pH. In a study of
Sobko et al. [19] the production of NO by fecal microbiota
cultivated on ISO-sensitest agar supplemented with nitrate
was demonstrated. For the plates supplemented with 1.4mg
NO3
−-N/L, concentrations in the range 29–3600ppbv NO,
corresponding to 1–145ng NO-N/L in the microbial suspen-
sion, were measured but a high variability was seen between8 Journal of Biomedicine and Biotechnology
diﬀerent fecal samples. As the pH of the plates decreased
from 7 to 5, a chemical reduction could not be excluded.
However, it was concluded that the fecal NO generation was
not solely due to acidiﬁcation of the plates [19]. We can con-
clude that the NO concentrations found in our study, which
were between 90 and 100ng NO/L for low concentrations of
nitrate, are in the same order of magnitude.
Under anaerobic conditions, bacteria can use nitrate as
N-source in nitrate assimilation and 2 dissimilatory pro-
cesses, denitriﬁcation and DNRA. Denitriﬁcation is assumed
to be the major nitrate removal pathway in many anoxic
ecosystems like soils, sediments, and water treatment plants
[20] but information about the occurrence of this process
in the human colon is limited [26]. Denitrifying bacteria are
found in Alpha-, Beta, Gamma- and Epsilonproteobacteria,
Firmicutes, and Bacteroidetes. During denitriﬁcation NO is
produced in the nanomolar range, without reaching toxic
levels [21, 22]. When the supply of electron acceptor is
limited, it is more beneﬁcial for the bacteria to exploit
DNRA rather than denitriﬁcation because of the higher
electron consumption [41]. Molecular and biochemical
studies have described DNRA in some enteric bacteria [42]
but information about the occurrence of this process in
complex microbial cultures including the microbiota of the
human gastrointestinal tract is limited [20]. Allison and
Macfarlane [26] reported that DNRA is the major pathway
for nitrate reduction by the fecal microbiota. Identiﬁcation
based on phenotype and genotype showed that Clostridium
ramosum, Bacteroides vulgates, and the enterobacteriaceae
were mainly capable of DNRA [27]. These species are rep-
resentative for the dominant groups of the fecal microbiota
[31, 32]. By adding the stable isotope 15N in the form
of nitrate, the occurrence of all nitrate-reducing processes
undergastrointestinalconditionswasstudiedandquantiﬁed.
Maximum 0.14 atom % of the added nitrate was used for
biomass production. High ammonium concentrations in
the medium repress nitrate assimilation and enhance the
use of nitrate for the dissimilatory processes [41]. Under
gastrointestinal conditions nitrate seems to be completely
reduced to ammonium and not to N2 gas and during this
reductive process, NO is produced in low concentrations. To
our knowledge, no studies are available indicating NO as an
intermediate in DNRA. Further proof for NO production
during DNRA was given by E. coli K12, a strain capable
of DNRA but not denitriﬁcation (data not shown) [27].
This strain produced 170ng NO-N/L under gastrointestinal
conditionswithlowconcentrationsofnitrate(110μgN O 3
−-
N/L).EvidenceforNOasanintermediateinDNRAwouldbe
even more decisive when 15N-NO was measured during the
15N tracer study. However, equipment for 15N-NO analyses
is very specialized [43] and not in the scope of this paper.
Whether N2O is an intermediate as well or the reduction
product of a defense mechanism of bacteria to NO [44]i s
not clear.
The gaseous NO concentration measured in the colon
ascendens (CA) vessel of the in vitro SHIME model was
around 15 times higher than the NO concentrations mea-
sured in the colon transversum (CT) and colon descendens
(CD). During the batch experiments incubation of the
microbialsuspensionfromthediﬀerentcolonvesselsshowed
that the NO concentration of the CA doubled when adding
fresh medium. The addition of fresh feed medium decreased
the diﬀerence in NO concentrations between the colon
vessels. Remarkably, when removing the supernatant of the
suspension, a 6-fold increase of NO was seen and the
diﬀerence between the colon vessels disappeared, indicating
that the availability of nutrients rather than a diﬀerence in
the microbial community was responsible for the diﬀerences
betweenthecolonvessels.Also,asimilarinhibitoryeﬀectwas
seen by adding the supernatant of the fecal suspension to the
inoculated buﬀered feed medium. Diluting the fecal suspen-
sion to increase NO production conﬁrmed our observation.
A possible explanation for this inhibitory eﬀect can be the
presence of bile salts. About 5% of the bile salts secreted in
the duodenum is available to the microbiota in the colon. To
protect them, the microbiota tend to hydrolyze the bile salts
but around 5% of the nonconverted bile salts can be found
in human feces and will have toxic eﬀects on the bacteria
[45]. Diluting the fecal suspension could decrease the toxic
eﬀect and thus increase the bacterial metabolism. The same
explanation might be valid for the lower NO concentrations
in the nonbuﬀered compared to the buﬀered feed medium
for the 2 lower concentrations of nitrate. As the pH drops
during the nonbuﬀered incubations, the metabolism of the
bacteria might be suppressed leading to a lower formation of
NO.
Epithelial cells are known to produce NO through
oxidation of L-arginine by NOS [4, 5]. Roediger et al. [46]
demonstrated elevated luminal NO in the rectum of patients
with active IBD. Although bacterial origin was considered,
the NO was believed to originate from the mucosa [46].
Several years later, NO concentrations were measured in the
rectum that was not cleared from luminal bacteria and again
NOconcentrationsin patients with activeIBDwereelevated.
A bacterial origin for the NO production was proposed [3].
Our results corroborate that the fecal microbiota actively
produce substantial levels of NO, even from traces of nitrate.
In vitro the fecal microbiota were shown to produce around
100ng NO-N/L. In vivo no NO was found in the rectum of
healthy volunteers but 40ng NO-N/L was measured in the
rectum of patients with active IBD [3]. Externally added NO
(in the form of gas or NO donor) has been shown to alter the
mucosalbarrierfunction[47–49]andtohaveaneﬀectonthe
metabolism of colonocytes [50]. As it was strongly suggested
that several constitutive and/or inducible defense systems
exist in mammalian cells that neutralize the damaging eﬀects
of NO [51], the high rectal levels of NO in IBD patients
and the low levels in healthy persons might indicate that the
expression of these defense mechanisms in IBD patients is
ineﬀective.
In this work, the human fecal microbiota were shown
to produce NO from trace levels of nitrate under gas-
trointestinal conditions. Moreover, our data indicate that
NO was produced by DNRA and not by denitriﬁcation or
the L-arginine pathway. Studying the interaction between
bacterially produced NO and the host epithelial cells might
be pivotal in the etiology of inﬂammatory diseases of the
gastrointestinal tract.Journal of Biomedicine and Biotechnology 9
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